CAS No. 73491-36-8

Chemical Identifiers

Linear Formula CF3O3STl
Pubchem CID 11024623
MDL Number MFCD00061608
EC No. N/A
IUPAC Name thallium(1+); trifluoromethanesulfonate
Beilstein/Reaxys No. N/A
SMILES C(F)(F)(F)S(=O)(=O)[O-].[Tl+]
InchI Identifier InChI=1S/CHF3O3S.Tl/c2-1(3,4)8(5,6)7;/h(H,5,6,7);/q;+1/p-1
InchI Key PDFSYPYWCONFDC-UHFFFAOYSA-M

Health & Safety Information

Signal Word Danger
Hazard Statements H300-H315-H319-H330-H335-H400
Hazard Codes T+, N
Risk Codes 26-28-33-36/37/38-51/53
Safety Statements 13-26-28-45-61
RTECS Number N/A
Transport Information UN 1707 6.1 / PGII
WGK Germany 3
GHS Pictograms

View and Print SDS

SAFETY DATA SHEET

Date Accessed: 11/04/2024
Date Revised: 01/15/2022

SECTION 1. IDENTIFICATION

Product Identifiers: All applicable American Elements product codes for CAS #73491-36-8

Relevant identified uses of the substance: Scientific research and development

Supplier details:
American Elements
10884 Weyburn Ave.
Los Angeles, CA 90024
Tel: +1 310-208-0551
Fax: +1 310-208-0351

Emergency telephone number:
Domestic, North America +1 800-424-9300
International +1 703-527-3887


SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
Acute toxicity, Oral (Category 2), H300
Acute toxicity, Inhalation (Category 2), H330
Skin irritation (Category 2), H315
Eye irritation (Category 2A), H319
Specific target organ toxicity - single exposure (Category 3), Respiratory system, H335
Acute aquatic toxicity (Category 1), H400
Chronic aquatic toxicity (Category 1), H410

2.2 GHS Label elements, including precautionary statements

Skull and Crossbones - GHS06 Environment - GHS09

Pictogram
Signal word Danger
Hazard statement(s)
H300 + H330 Fatal if swallowed or if inhaled
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H410 Very toxic to aquatic life with long lasting effects.
Precautionary statement(s)
P260 Do not breathe dust/ fume/ gas/ mist/ Vapors/ spray.
P264 Wash skin thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P271 Use only outdoors or in a well-ventilated area.
P273 Avoid release to the environment.
P280 Wear protective gloves/ eye protection/ face protection.
P284 Wear respiratory protection.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position
comfortable for breathing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P310 Immediately call a POISON CENTER or doctor/ physician.
P320 Specific treatment is urgent (see supplemental first aid instructions on
this label).
P330 Rinse mouth.
P332 + P313 If skin irritation occurs: Get medical advice/ attention.
P337 + P313 If eye irritation persists: Get medical advice/ attention.
P362 Take off contaminated clothing and wash before reuse.
P391 Collect spillage.
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none


SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances
Synonyms : Tl(OTf)
Formula : CF3O3STl
Molecular weight : 353.45 g/mol
CAS-No. : 73491-36-8
Hazardous components
Component Classification Concentration
Thallium(I) trifluoromethanesulfonate
Acute Tox. 2; Skin Irrit. 2; Eye
Irrit. 2A; STOT SE 3; Aquatic
Acute 1; Aquatic Chronic 1;
H300 + H330, H315, H319,
H335, H410
<= 100 %


SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11
4.3 Indication of any immediate medical attention and special treatment needed
For thallium antidote, see Eur. J. Pharmacol., 6, 340 (1969).


SECTION 5. FIREFIGHTING MEASURES

5.1 Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
Carbon oxides, Sulphur oxides, Hydrogen fluoride, thallium oxides
5.3 Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
5.4 Further information
No data available


SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
6.2 Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment
must be avoided.
6.3 Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for
disposal.
6.4 Reference to other sections
For disposal see section 13.


SECTION 7. HANDLING AND STORAGE

7.1 Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
7.2 Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature 2 - 8 °C
Store under inert gas. Moisture sensitive. Keep in a dry place.
7.3 Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated


SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters
Components with workplace control parameters
Contains no substances with occupational exposure limit values.
8.2 Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate
government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without
touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after
use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0.11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0.11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Aldrich Z677272, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, e-mail sales@kcl.de, test method:
EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374, contact the
supplier of the CE approved gloves. This recommendation is advisory only and must be evaluated by an
industrial hygienist and safety officer familiar with the specific situation of anticipated use by our customers. It
should not be construed as offering an approval for any specific use scenario.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected according to
the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type
N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the
sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.


SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odor No data available
c) Odor Threshold No data available
d) pH No data available
e) Melting point/freezing
point
Melting point/range: 245 - 250 °C (473 - 482 °F)
f) Initial boiling point and
boiling range
No data available
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapor pressure No data available
l) Vapor density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: noctanol/
water
No data available
p) Auto-ignition
temperature
No data available
q) Decomposition
temperature
No data available
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
9.2 Other safety information
No data available


SECTION 10. STABILITY AND REACTIVITY

10.1 Reactivity
No data available
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
No data available
10.4 Conditions to avoid
No data available
10.5 Incompatible materials
Strong oxidizing agents
10.6 Hazardous decomposition products
In the event of fire: see section 5


SECTION 11. TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects
Acute toxicity
No data available
Inhalation: No data available
Dermal: No data available
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by ACGIH.
NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
No data available
No data available
Specific target organ toxicity - single exposure
May cause respiratory irritation.
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
The most characteristic symptom of thallium exposure is alopecia (loss of hair). Cutaneous effects may include dry,
scaly skin and impairment of nail growth often resulting in the appearance of crescent-shaped strips across fingernails
and toenails (Mees' line). Other symptoms in acute poisoning relate chiefly to the gastrointestinal tract, nervous
system, skin, eyes, and cardiovascular system. Acute poisoning results in swelling of the feet and legs, arthralgia,
vomiting, insomnia, hyperesthesia and paresthesia of the hands and feet, mental confusion, polyneuritis with severe
pain in the legs and loins, partial paralysis of the legs, angina-like pains, nephritis, wasting and weakness, and
lymphocytosis and eosinophilia. In chronic poisoning, central and peripheral nervous system abnormalities may persist
including ataxia, tremor, incoordination, paralysis of extremities, endocrine disorders, memory loss, and psychoses
may develop., To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Stomach - Irregularities - Based on Human Evidence
Stomach - Irregularities - Based on Human Evidence


SECTION 12. ECOLOGICAL INFORMATION

12.1 Toxicity
No data available
12.2 Persistence and degradability
No data available
12.3 Bioaccumulative potential
No data available
12.4 Mobility in soil
No data available
12.5 Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
12.6 Other adverse effects
An environmental hazard cannot be excluded in the event of unprofessional handling or disposal.
Very toxic to aquatic life


SECTION 13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste
disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a
chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.


SECTION 14. TRANSPORT INFORMATION

DOT (US)
UN number: 1707 Class: 6.1 Packing group: II
Proper shipping name: Thallium compounds, n.o.s. (Thallium(I) trifluoromethanesulfonate)
Reportable Quantity (RQ):
Marine pollutant:yes
Poison Inhalation Hazard: No
IMDG
UN number: 1707 Class: 6.1 Packing group: II EMS-No: F-A, S-A
Proper shipping name: THALLIUM COMPOUND, N.O.S. (Thallium(I) trifluoromethanesulfonate)
Marine pollutant:yes Marine pollutant: yes
IATA
UN number: 1707 Class: 6.1 Packing group: II
Proper shipping name: Thallium compound, n.o.s. (Thallium(I) trifluoromethanesulfonate)


SECTION 15. REGULATORY INFORMATION

SARA 302 Components
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
This material does not contain any chemical components with known CAS numbers that exceed the threshold (De
Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
Thallium(I) trifluoromethanesulfonate
CAS-No.
73491-36-8
Revision Date
New Jersey Right To Know Components
Thallium(I) trifluoromethanesulfonate
CAS-No.
73491-36-8
Revision Date
California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other
reproductive harm.


16. OTHER INFORMATION

Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH). The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. American Elements shall not be held liable for any damage resulting from handling or from contact with the above product. See reverse side of invoice or packing slip for additional terms and conditions of sale. COPYRIGHT 1997-2022 AMERICAN ELEMENTS. LICENSED GRANTED TO MAKE UNLIMITED PAPER COPIES FOR INTERNAL USE ONLY.